Pharmaceutical companies have long gotten a bad rap for trying to influence medical decisions for a profit – but the issue isn’t exclusive to drugs. New York Times reporter Roni Caryn Rabin recently wrote about aggressive tactics used to market the Da Vinci Surgical System – a robotic assistant now operating in over 1300 hospitals across the United States.
Closing The Sale: Robot Surgeons
Fort Bellvoir Community Hospital via flickr Creative Commons
